“…[29,30] It could even lead to cholestasis and hepatotoxicity after liver transplantation. [31] Most of these risks are due to its molecular interactions at inappropriate doses. [32] For tacrolimus, various dispersion concentrations in donor liver tissue may bring different consequences; therefore, the crucial factor of tacrolimus therapy may be the balance between immunosuppression and toxic overdose.…”